About this trial

The aim of the current project is to investigate the impact of 3mg of oral estradiol valerate on the formation of intrusive memories after analog trauma.

A well-established stress-film paradigm will be used to induce intrusive symptoms in healthy participants. In a double-blind placebo-controlled study, the impact of oral estradiol on intrusive symptoms during and immediately after exposure to a trauma film will be examined. The primary hypothesis is that exogenous oral estradiol will decrease the number of intrusive memories recorded in the four days following experimental trauma compared with placebo controls.

This project will contribute to the current understanding of intrusive memory formation in PTSD and may guide the development of future pharmacological preventions.

Eligibility criteria

Qualifiers

healthy female volunteers

German on B1 level

Disqualifiers

former or present disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5)

any physical illnesses

any medication intake (except oral contraceptive)

history of traumatic experience, e.g. history of sexual abuse or rape

Trial design

Treatments tested in this trial

  • Estradiol Valerate
  • Placebo

Treatment groups

273 Participants
are divided into 3 treatment groups

Locations

1
Charité - Universitätsmedizin Berlin12203, BerlinState of Berlin, Germany

Sponsors and collaborators

Charite University, Berlin, Germany

Lead sponsor